Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4023153018 | Brexucabtagene autoleucel-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4023154012 | Product containing brexucabtagene autoleucel (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brexucabtagene autoleucel-containing product | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Brexucabtagene autoleucel-containing product | Is a | Medicinal product acting as antineoplastic agent (product) | false | Inferred relationship | Some | ||
| Brexucabtagene autoleucel-containing product | Is a | Product containing genetically modified T-cell (product) | true | Inferred relationship | Some | ||
| Brexucabtagene autoleucel-containing product | Has active ingredient | Brexucabtagene autoleucel | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brexucabtagene autoleucel only product | Is a | True | Brexucabtagene autoleucel-containing product | Inferred relationship | Some | |
| Brexucabtagene autoleucel-containing product in parenteral dose form | Is a | True | Brexucabtagene autoleucel-containing product | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR